Your browser doesn't support javascript.
loading
Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma.
Chi, Andrew S; Cahill, Daniel P; Reardon, David A; Wen, Patrick Y; Mikkelsen, Tom; Peereboom, David M; Wong, Eric T; Gerstner, Elizabeth R; Dietrich, Jorg; Plotkin, Scott R; Norden, Andrew D; Lee, Eudocia Q; Nayak, Lakshmi; Tanaka, Shota; Wakimoto, Hiroaki; Lelic, Nina; Koerner, Mara V; Klofas, Lindsay K; Bertalan, Mia S; Arrillaga-Romany, Isabel C; Betensky, Rebecca A; Curry, William T; Borger, Darrel R; Balaj, Leonora; Kitchen, Robert R; Chakrabortty, Sudipto K; Valentino, Michael D; Skog, Johan; Breakefield, Xandra O; Iafrate, A John; Batchelor, Tracy T.
Afiliação
  • Chi AS; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Cahill DP; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Reardon DA; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA.
  • Wen PY; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA.
  • Mikkelsen T; Ontario Brain Institute, Toronto, Ontario, Canada.
  • Peereboom DM; Henry Ford Hospital, Detroit, MI.
  • Wong ET; Cleveland Clinic, Cleveland, OH.
  • Gerstner ER; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
  • Dietrich J; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Plotkin SR; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Norden AD; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Lee EQ; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA.
  • Nayak L; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA.
  • Tanaka S; Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, MA.
  • Wakimoto H; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Lelic N; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Koerner MV; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Klofas LK; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Bertalan MS; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Arrillaga-Romany IC; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Betensky RA; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Curry WT; Harvard School of Public Health, Boston, MA.
  • Borger DR; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Balaj L; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Kitchen RR; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Chakrabortty SK; Exosome Diagnostics, Waltham, MA.
  • Valentino MD; Exosome Diagnostics, Waltham, MA.
  • Skog J; Exosome Diagnostics, Waltham, MA.
  • Breakefield XO; Exosome Diagnostics, Waltham, MA.
  • Iafrate AJ; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • Batchelor TT; Massachusetts General Hospital and Harvard Medical School, Boston, MA.
JCO Precis Oncol ; 42020.
Article em En | MEDLINE | ID: mdl-32923886
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Marrocos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Marrocos